graphic image of China flags overlapping with US flags
Biotech

Eli Lilly reunites with Abbisko in $1.9B, multitarget R&D pact

Lilly has expanded its ties to Abbisko, committing up to $1.9 billion to get the Chinese biotech to apply its capabilities to multiple targets.
Nick Paul Taylor Jun 24, 2026 7:47am
Person throwing piece of paper into full waste bin
Favicon Fierce Pharma

Nature retracts provocative PD-1 time-of-day study

Jun 24, 2026 11:00am
ipsen-heropng

Redefining PSC success through endpoint research.

Brought to you by Ipsen
x

Fierce Biotech Layoff Tracker 2026: ADC Tx, Sangamo & more

Jun 24, 2026 11:00am
For biopharma manufacturing at speed and scale the future is flexible

For biopharma manufacturing at speed and scale, the future is flexible

Brought to you by Resilience
dollar sign with colored arrows in a maze

RQ nabs $115M to advance flu prevention antiviral

Jun 24, 2026 9:43am
More News

Novartis pays Antares $105M to tackle undruggable cancer targets

Jun 24, 2026 9:13am

Fierce Biotech Fundraising Tracker '26: Ollin, RQ Bio & more

Jun 24, 2026 9:00am

Flagship inks deal with Saudi sovereign wealth fund company

Jun 24, 2026 8:24am

Ollin hauls in $330M for Vabysmo challenger's ph. 3 gauntlet

Jun 24, 2026 7:00am